C
Caribou Biosciences, Inc. (CRBU)
NMS – Real Time Price. Currency in USD
2.03
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
2.09
+0.06 (2.71%)
After-hours: May 12, 2026, 7:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
2.03
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
2.09
+0.06 (2.71%)
After-hours: May 12, 2026, 7:50 PM EDT
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
| Name | Position |
|---|---|
| Dr. Jennifer A. Doudna Ph.D. | Co-founder & Member of Scientific Advisory Board |
| Dr. Rachel E. Haurwitz Ph.D. | Co-Founder, CEO, President & Director |
| Dr. Tina Albertson M.D., Ph.D. | Chief Medical Officer |
| Mr. Ryan Fischesser | Interim Principal Accounting Officer & Controller |
| Mr. Sriram Ryali M.B.A. | Chief Financial Officer |
| Mr. Timothy P. Kelly M.B.A. | Chief Technology Officer |
| Ms. Barbara G. McClung Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Ms. Reigin Zawadzki | Chief People Officer |
| Ms. Ruhi A. Khan M.B.A. | Chief Business Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | crbu-20260507.htm |
| 2026-05-01 | DEFR14A | crbu-20260501.htm |
| 2026-04-24 | DEFA14A | cariboubiosciencesinc_vx.htm |
| 2026-04-24 | DEF 14A | crbu-20260423.htm |
| 2026-04-10 | PRE 14A | crbu-20260410.htm |
| 2026-03-31 | 8-K | crbu-20260331.htm |
| 2026-03-05 | 8-K | crbu-20260305.htm |
| 2026-03-05 | 10-K | crbu-20251231.htm |
| 2025-11-12 | 10-Q | crbu-20250930.htm |
| 2025-11-03 | 8-K | crbu-20251103.htm |